Insider buying last 90 days
$101Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 11 | McQUADE KATHRYN B. director | Purchase | $101K |
From Form 4 filings, dated to when each was filed.
Altria shares climbed this week, with October gains of 15.9% attributed to solid earnings driven by price increases and a smaller-than-expected volume decline. The company's Q3 2026 results showed 4.8% adjusted diluted EPS growth, with on! nicotine pouches posting 13.3% shipment volume growth to 47.8 million cans and retail share at 8.3%; Helix also expanded on! PLUS 12-milligram nationally. Altria announced its 61st dividend increase alongside a $1 billion share repurchase program. Analyst actions were mixed: Barclays raised its price target to $60.00 while maintaining an "underweight" rating, UBS Group raised its target from $79.00 to $83.00 with a "buy" rating, and the stock was also compared against peer Philip Morris (PM) on dividend yield and growth appeal.
MO closed at $78.01, up 1.4%, sitting above both its 50-day average of $71.05 and 200-day average of $69.12. The GekkoIndex reads 44.3, placing the stock in the Distribution zone, down from a five-day change of -10.2. Price remains 7.5% below Gekko Fair Value of $84.33.
The next earnings date falls on 4 February 2027, outside the typical 20-trading-day window. Over the last 90 days, smart money activity includes one insider purchase and one Congressional buy with no sales. Seasonality over five years shows an average 2.8% gain across the next 20 trading days, with gains in 4 of those years. The consensus analyst target sits at $73.45, with 8 firms covering the stock.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Altria scores 5 supportive, 0 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive0 mixed1 headwind
Above 50 and 200-day
Close $78.01 is above the 50-day ($71.05) and 200-day ($69.12) averages, and the 50-day is above the 200-day.
See the chart44.3, Distribution
Reading 44.3 is in the Distribution zone.
See the GekkoIndex7.5% below
Price is 7.5% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase; Congress 1 buy / 0 sales.
See smart moneyReports in 91 days
Next report Feb 4, 2027, 91 days away — outside a typical 20-trading-day hold.
See earnings+2.8% on average
From this point in the calendar, the next 20 trading days averaged +2.8% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Altria closed at $78.01 on Nov 4, 2026, +37.7% over the past year, inside a 52-week range of $54.70 to $79.81.
Use the left and right arrow keys to read daily values.
Put MO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Altria makes and sells tobacco products across the United States through a group of subsidiaries. Its lineup covers combustible goods such as cigarettes sold under the Marlboro name, along with cigars and pipe tobacco marketed mainly as Black & Mild. It also offers oral tobacco items, including moist smokeless brands like Copenhagen, Skoal, Red Seal, and Husky, plus the on! line of nicotine pouches.
The company moves its products mainly through wholesale channels, working with independent distributors, and it also sells directly to large retail chains. This dual approach gives it reach into both smaller distribution networks and major store operations.
Altria was founded in 1822 and is headquartered in Richmond, Virginia. Its shares are listed on the NYSE under the ticker MO.
Altria’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 44.3, in the Distribution zone, down 10.2 points over five sessions.
Down 10.2 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 19 | +2.5% | +4.6% | ||
| Accumulation | 199 | +0.7% | +3.4% | ||
| Neutral | 408 | +0.4% | +1.6% | ||
| Distribution (current zone) | 70 | 0.0% | −1.1% | ||
| Selling | 1 | Too few readings yet | |||
Average MO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
Altria trades 7.5% below Gekko Fair Value of $84.33, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Altria shares are worth, recalculated every trading day.
$84.33
Gekko Fair Value, Nov 4, 2026
7.5% Undervalued
At the end of Aug 2026 the price was 18.3% below the estimate.
Insiders filed 1 open-market purchase in Altria worth $101K, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$101Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 11 | McQUADE KATHRYN B. director | Purchase | $101K |
From Form 4 filings, dated to when each was filed.
1trade disclosed: 1 purchase and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
From congressional disclosures, which report amounts as ranges.
Altria has been buying back its own shares.
From company filings.
Altria reports on Feb 4, 2027, before the open (91 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 4, 2027
Expected before the open, 91 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 29, 2026 | $1.52 est $1.51 | $5.44B est $5.31B | +6.9% |
| Jul 30, 2026 | $1.48 est $1.50 | $5.36B est $5.35B | −8.8% |
| Apr 30, 2026 | $1.32 est $1.25 | $4.76B est $4.58B | +9.3% |
| Jan 29, 2026 | $1.30 est $1.32 | $5.08B est $5.03B | −1.8% |
| Oct 30, 2025 | $1.45 est $1.44 | $5.25B est $5.29B | −9.0% |
| Jul 30, 2025 | $1.44 est $1.39 | $5.29B est $5.19B | +4.3% |
| Apr 29, 2025 | $1.23 est $1.19 | $4.52B est $4.62B | +1.6% |
| Jan 30, 2025 | $1.29 est $1.28 | $5.11B est $5.05B | −0.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Altria is $73.45, −5.8% from the last close, from 8 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 8 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 2 | Barclays | $60 | −23.1% |
| Oct 30 | Stifel Nicolaus | $82 | +5.1% |
| Oct 30 | Morgan Stanley | $77 | −1.3% |
| Oct 30 | Morgan Stanley | $77 | −1.3% |
| Oct 30 | UBS | $83 | +6.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Altria averaged +2.8% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.3% | 3 of 5 |
| Next 10 trading days | +0.7% | 3 of 5 |
| Next 15 trading days | +1.3% | 3 of 5 |
| Next 20 trading days | +2.8% | 4 of 5 |
| Next 30 trading days | +3.5% | 5 of 5 |
For scale, MO’s typical 20-trading-day move in either direction is about 4%.
Altria’s market cap is $129.8B, with a P/E ratio of 15.9 and revenue of $20.63B over the last twelve months.
Coverage of Altria this week reads positive: 10 positive, 8 neutral and 3 negative headlines.
Altria’s market cap is $129.8B at the Nov 4, 2026 close of $78.01, with 1.66B shares outstanding. The shares trade on a P/E ratio of 15.9.
The consensus analyst 12-month price target for Altria is $73.45, −5.8% from the last close. Of the 8 firms that rated the stock in the last 90 days, 4 rate it a buy, 3 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Altria is undervalued: the Nov 4, 2026 close of $78.01 is 7.5% below Gekko Fair Value of $84.33. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Altria is expected to report on Feb 4, 2027, before the market opens (91 days away). Analysts expect earnings of $1.40 per share on revenue of $5.17B. Altria beat the earnings estimate in 6 of its last 8 reports, moving 5.3% on average across the report.
Altria’s 52-week high is $79.81 and its 52-week low is $54.70; it closed at $78.01 on Nov 4, 2026, +37.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (trend, fair value, smart money, earnings risk and seasonality) and 1 as a headwind (gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.